VPC

Vestal Point Capital Portfolio holdings

AUM $2.2B
1-Year Est. Return 36.26%
This Quarter Est. Return
1 Year Est. Return
+36.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.2B
AUM Growth
+$305M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$84.9M
2
+$79.5M
3
+$56.2M
4
RGEN icon
Repligen
RGEN
+$53.5M
5
DXCM icon
DexCom
DXCM
+$43.7M

Top Sells

1
+$203M
2
+$124M
3
+$123M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$92.3M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$79.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKUR
76
OnKure Therapeutics
OKUR
$41.6M
$1.75M 0.08%
635,000
LUNG icon
77
Pulmonx
LUNG
$104M
$1.34M 0.06%
+830,000
MGNX icon
78
MacroGenics
MGNX
$88.6M
$470K 0.02%
280,000
TENX icon
79
Tenax Therapeutics
TENX
$64.7M
$407K 0.02%
53,439
TRAW icon
80
Traws Pharma
TRAW
$18.6M
$278K 0.01%
150,000
+200
COGT icon
81
Cogent Biosciences
COGT
$6.46B
– –
-3,080,000
COO icon
82
Cooper Companies
COO
$16.1B
– –
-350,000
EW icon
83
Edwards Lifesciences
EW
$48.2B
– –
-300,000
GEHC icon
84
GE HealthCare
GEHC
$38.2B
– –
-700,000
MDT icon
85
Medtronic
MDT
$128B
– –
-195,000
MLTX icon
86
MoonLake Immunotherapeutics
MLTX
$1.05B
– –
-550,000
NBIX icon
87
Neurocrine Biosciences
NBIX
$15.2B
– –
-30,000
PRGO icon
88
Perrigo
PRGO
$1.81B
– –
-625,000
ATRA icon
89
Atara Biotherapeutics
ATRA
$130M
– –
-94,085
BHVN icon
90
Biohaven
BHVN
$1.53B
– –
0
GPCR icon
91
Structure Therapeutics
GPCR
$4.07B
– –
-1,200,000
TMO icon
92
Thermo Fisher Scientific
TMO
$215B
– –
-25,000
TVTX icon
93
Travere Therapeutics
TVTX
$3.12B
– –
-355,000
VRDN icon
94
Viridian Therapeutics
VRDN
$3.08B
– –
-100,000
ZBH icon
95
Zimmer Biomet
ZBH
$18.2B
– –
-50,000
1 2 3
4